Emergency Contraceptive Pills Market by Distribution channel, Tyep, and Geography - Forecast and Analysis 2023-2027

Emergency Contraceptive Pills Market Forecast 2023-2027

The emergency contraceptive pills market is estimated to grow by USD 258.7 million. at a CAGR of 4.83% between 2022 and 2027. The growth of the market is influenced by several factors, including the rise in initiatives to create awareness about contraception methods and their importance. The increase in unplanned pregnancies is also driving the demand for contraceptives, as individuals seek effective methods to prevent unintended pregnancies. Additionally, the ease of online purchases has made contraceptives more accessible, further contributing to market growth. It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Emergency Contraceptive Pills Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

This report extensively covers market segmentation by distribution channel (retail stores and online stores), type (combination pills and progesterone pills), and geography in North America, Europe, Asia, and the Rest of the World (ROW). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021. 

What are the Fastest-Growing Segments in the Market?

The market share growth by the retail stores segment will be significant during the forecast period. Retail stores include supermarkets, hypermarkets, departmental stores, pharmacies and clinics, and other stores. The increase in disposable income and the availability of emergency contraceptive pills across different retail stores have made purchases convenient for consumers. In addition, the market has witnessed a rise in promotional offers by local pharmacy chains, which is leading to an increase in the sale of emergency contraceptive pills. 

Get a glance at the market contribution of various segments Request a PDF Sample

The retail stores segment showed a gradual increase in the market share of USD 542.12 million in 2017 and continued to grow by 2021. Retail stores offer a range of options to consumers and have a strong presence in neighborhoods. The steady rise in the number of stores offering feminine contraceptive products is increasing the share of the retail stores segment in the global market. 

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to account for 37% of the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

High product awareness and ease of availability in pharmacies, clinics, and online stores are driving the growth of the market in the region. Also, the increased incidences of unplanned pregnancies and widespread awareness regarding their ease of use have driven the market significantly. In addition, the region has a large number of companies, such as Afaxys, Foundation Consumer Healthcare, and Syzygy Healthcare, which allow effective distribution and timely availability of these products. 

Market Dynamics and Customer Landscape

The market is influenced by organizations like the United Nations Populations Fund and advisory bodies such as the Advisory Committee on Immunization Practices (ACIP). Companies like Mayne Pharma offer ECP options like Drospirenone Tablets and Slynd Tablets to address demand surges. Reproductive health services play a crucial role, especially with abortion restrictions affecting access. The market includes OTC products like Plan B medication and pre-coital contraceptives such as Wisp, catering to sexually active women seeking emergency contraception. This market, including condoms and birth control options, serves a critical need for women worldwide, as highlighted by the Kaiser Family Foundation.  A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage. 

Key Market Driver

The rise in the number of initiatives to create awareness is notably driving the growth. Several governments and academic institutes are promoting the use of contraception, including emergency contraceptive pills. They are launching initiatives to aid individual users in acquiring cost-effective contraceptive solutions. For instance, NHS, through its service finder, allows a user to find a pharmacy or a clinic nearby to procure contraceptives.

According to WHO, each year, 74 million women living in low and middle-income countries have an unintended pregnancy. The unplanned pregnancies are a result of a lack of information about contraception, sexual health, and a lack of open communication about sex. Hence, countries are taking initiatives aimed at reducing the rate of unplanned conceptions. These include advertising campaigns; sex education; access to and information about contraceptives; and discussion on sexual health with general practitioners, youth services, and specialized clinics. Thus, high awareness about contraception products such as emergency contraception pills is expected to fuel the market growth during the forecast period.

Major Market Trend

The importance of family planning is a key trend influencing the market growth. Unplanned pregnancies are a result of unprotected sexual intercourse, contraceptive failure, incorrect use of contraceptives, and sexual assault. The use of effective contraception can prevent abortion-related and pregnancy-related morbidity and mortality cases in developing countries.

Many organizations promote voluntary family planning. Organizations such as the Asia Pacific Council on Contraception, the European Society of Cardiology, and the International Planned Parenthood Federation conduct programs to spread awareness about contraceptive drugs, such as emergency contraceptive pills. Government initiatives toward family planning and easy access to contraceptives have increased the popularity of contraceptive pills. Thus, an increase in awareness about the importance of family planning will support the growth of the market during the forecast period. 

Signification Market Challenge

Local governments limiting access to emergency contraceptive pills may impede market growth. In 2013, the FDA approved the Plan B One-Step contraceptive pill, which can be acquired without prescription or age restrictions. However, the distribution of such products is restricted on moral or ethical grounds.

For instance, states such as Massachusetts and the District of Columbia in the US require emergency rooms to dispense the drug on request to sexual assault victims. However, other states such as Arizona, Arkansas, Georgia, Idaho, Mississippi, and South Dakota do not allow pharmacists to dispense contraceptives, including emergency contraception pills. The presence of such restrictions limits the adoption of emergency contraception pills in the US, which is an important market for companies. This leads to a loss of potential revenue for companies and hampers market growth.

Key Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Emergency Contraceptive Pills Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

• AbbVie Inc. - The company offers an emergency contraceptive pill, namely Liletta.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

• Afaxys Pharma LLC
• Bayer AG
• Combe Inc.
• Foundation Consumer Healthcare LLC
• Gedeon Richter Plc
• HLL Lifecare Ltd.
• Knoll Healthcare Pvt. Ltd.
• Laboratoire HRA Pharma SAS
• Lupin Ltd.
• Mankind Pharma Ltd.
• Morepen Laboratories Ltd.
• Perrigo Co. Plc
• Pfizer Inc.
• Piramal Enterprises Ltd.
• Sun Pharmaceutical Industries Ltd.
• Syzygy Healthcare LLC
• Teva Pharmaceutical Industries Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The report forecasts market growth by revenue at global, regional, and country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Distribution Channel (Retail stores and Online stores), Type (Combination pills and Progesterone pills), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

• Distribution Channel Outlook
  • Retail stores
  • Online stores

• Type Outlook 
  • Combination pills
  • Progesterone pills

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Brazil
    • South Africa
    • Australia

Market Analyst Overview

The market is influenced by factors such as the availability of estrogen-progestin birth control pills and ulipristal acetate. These pills are accessible through various distribution channels, including hospital pharmacies. The market is segmented based on regional insights, with regions like the Southeast and Midwest playing significant roles. The market is characterized by branded and generic providers, with a focus on strategic initiatives to enhance market share. Despite challenges such as abortion bans, the market continues to grow. Key research published in journals like the Journal of The American Pharmacists Association and the National Library of Medicine drive advancements in emergency contraceptive pills, including combined oral contraceptives and estrogen pills, contributing to the global market for these products.

The market is a vital segment of the pharmaceutical industry and plays a crucial role in healthcare systems worldwide. In the progesterone pills segment, efficacy rate and revenue share are key factors. The combination pills segment also contributes significantly, with considerations for pharmacy availability. Distribution channels such as the retail store segment and online store segment are essential for accessibility. Regional insights, particularly from the Southeast regions and Midwest regions, provide valuable market data. Key companies in the market focus on strategic initiatives to improve their market share. Research on factors like calcium and sodium ions and male mice contributes to advancements in emergency contraceptive technologies.

Furthermore, the market is influenced by various factors, including guidance from organizations like the Taiwan Centers for Disease Control and the Advisory Committee on Immunization Practices (ACIP). Initiatives by the United Nations Populations Fund and the Council of Ministers of Spain also play a role. Companies like Mayne Pharma offer products like Drospirenone Tablets, Slynd Tablets, and Drovelis. Other key players include Organon, Marvelon, and Mercilon. There's a growing demand for morning-after pills like Wisp due to increased awareness about contraception and family planning. However, challenges such as abortion restrictions and supply chain disruptions impact the market. The availability of over-the-counter (OTC) products like Plan B medication is also a significant factor, particularly for sexually active women seeking reproductive health services and pre-coital contraceptives.

The global market for emergency contraceptive pills (ECPs) is witnessing significant growth, driven by increasing awareness about reproductive health and the availability of over-the-counter (OTC) options. Distribution channel insights reveal a diverse landscape, including pharmacies,  online retailers, and healthcare facilities, catering to the diverse needs of consumers worldwide. Key companies in this market, such as the American Chemical Society and others, play a pivotal role in driving innovation and expanding market reach. With a focus on research and development, these companies strive to enhance product efficacy and accessibility, contributing to market growth and competitiveness. Market share insights indicate a competitive environment, with prominent players vying for market dominance through strategic initiatives such as product launches, partnerships, and acquisitions. As the demand for emergency contraceptive pills continues to rise, stakeholders must stay abreast of evolving market dynamics Share Insights to capitalize on emerging opportunities and maintain a competitive edge.

Emergency Contraceptive Pills Market Scope
Report Coverage	Details
Page number	154
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 4.83%
Market growth 2023-2027	USD 258.7 million
Market structure	Fragmented
YoY growth 2022-2023(%)	3.72
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 37%
Key countries	US, China, Japan, Germany, and France
Competitive landscape	Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd.
Market dynamics	Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch